Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on November 21, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn320
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
81/2/294    most recent
cvn320v2
cvn320v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Darmellah, A.
Right arrow Articles by Feuvray, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darmellah, A.
Right arrow Articles by Feuvray, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org.

ERM proteins mediate the effects of Na+/H+ exchanger NHE1 activation in cardiac myocytes

Amaria Darmellah, Catherine Rücker-Martin and Danielle Feuvray*

University of Paris-Sud 11 & CNRS UMR 8162, Marie Lannelongue Hospital, Le Plessis Robinson, France

* Address for correspondence: Dr Danielle Feuvray, UMR CNRS 8162 - Université Paris-Sud 11, Hôpital Marie Lannelongue,133 avenue de la Résistance, 92350 Le Plessis Robinson, France, tel: 33-1 40 94 25 21, fax: 33-1 40 94 25 22, e-mail: danielle.feuvray{at}u-psud.fr

Aims: Ezrin, radixin and moesin (ERM) proteins have been implicated in regulating signalling molecules. The aim of the present study was to investigate the activity and subcellular distribution of ERM proteins in cardiac myocytes from both Wistar and diabetic Goto-Kakizaki (GK) rats, and the role of these proteins in mediating the downstream effects of the cardiac sarcolemmal Na+/H+ exchanger (NHE1) activation in response to cell acidification.

Methods and results: Immunofluorescence microscopy revealed that activated ERM proteins were localised predominantly at the intercalated disc regions in left ventricular (LV) myocytes from both Wistar and GK rats under basal conditions. After acid loading, profound changes in activated ERM distribution were observed in both groups of myocytes, with immunolabelling detected in regions corresponding to the transverse tubules. This correlated with a marked increase in phospho-ERM levels in both groups, which was higher in GK myocytes and blocked by NHE1 inhibitor treatment. Levels of phospho-Akt paralleled those of phospho-ERM under the various experimental conditions used; in particular, the marked acid-induced increase in both phospho-ERM and phospho-Akt in GK myocytes was abolished by an NHE1 inhibitor treatment. Moreover, the pattern of glycogen synthase kinase 3β (GSK-3β) phosphorylation in these myocytes was strikingly similar to that observed for Akt activity under the conditions used.

Conclusions: Activated ERM proteins mediate the effects of acid-induced NHE1 activation in LV myocytes. Akt is a downstream effector in the cascade activated by NHE1/ERM interaction. In addition, GSK-3β phosphorylation is required for downstream effects of NHE1/ERM-Akt signalling.

KEYWORDS Cardiac myocytes; ERM; NHE1; Akt; GSK3β; Intracellular acidification; Hypertrophy

Time for primary review: 36 Days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.